Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Dr. Hengshuo Liu
Technical Sales Supervisor
Topic:
Addressing Challenges in Antibody-Drug Conjugate Development
Antibody-drug conjugates (ADCs) are a cutting-edge class of targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, allowing for the precise delivery of chemotherapy to cancer cells while minimizing damage to healthy tissue. Despite their promise, the development of ADCs faces significant challenges, including optimizing the stability of the conjugate, ensuring effective drug release at the target site, and managing potential off-target effects. This webinar will explore the latest advancements in ADC technology and strategies to overcome these critical hurdles in drug development.
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.
This web search service is supported by Google Inc.
A-Z
